Novo Integrated Sciences Q2 EPS $(0.16) Up From $(0.59) YoY, Sales $3.17M Up From $2.56M YoY
Portfolio Pulse from Benzinga Newsdesk
Novo Integrated Sciences (NASDAQ:NVOS) reported a significant improvement in its Q2 earnings, with a loss per share narrowing to $(0.16) from $(0.59) YoY. Sales also increased to $3.17M from $2.56M YoY, marking a 24.00% growth.
April 15, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novo Integrated Sciences reported a narrower loss of $(0.16) per share in Q2, improving from $(0.59) YoY, and a 24% increase in sales to $3.17M from $2.56M YoY.
The significant improvement in both earnings per share and sales indicates a strong quarter for Novo Integrated Sciences. The reduction in losses and increase in sales are likely to be viewed positively by investors, potentially leading to a short-term uptick in NVOS's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100